Prognostic Values of the Integrated Model Incorporating the Volume of Metastatic Regional Cervical Lymph Node and Pretreatment Serum Epstein–Barr Virus DNA Copy Number in Predicting Distant Metastasis in Patients with N1 Nasopharyngeal Carcinoma

Ji-Jin Yao,Guan-Qun Zhou,Ya-Qin Wang,Si-Yang Wang,Wang-Jian Zhang,Ya-Nan Jin,Fan Zhang,Li,Li-Zhi Liu,Zhi-Bin Cheng,Jun Ma,Zhen-Yu Qi,Ying Sun
DOI: https://doi.org/10.1186/s40880-017-0264-x
2017-01-01
Abstract:According to the 7th edition of the American Joint Committee on Cancer (AJCC) staging system, over 50% of patients with nasopharyngeal carcinoma (NPC) have N1 disease at initial diagnosis. However, patients with N1 NPC are relatively under-researched, and the metastasis risk of this group is not well-stratified. This study aimed to evaluate the prognostic values of gross tumor volume of metastatic regional lymph node (GTVnd) and pretreatment serum copy number of Epstein–Barr virus (EBV) DNA in predicting distant metastasis of patients with N1 NPC, and to develop an integrated prognostic model that incorporates GTVnd and EBV DNA copy number for this group of patients.
What problem does this paper attempt to address?